A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

NCT05718492 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

PROCEDURE: digital subtraction angiography.
DRUG: FOLFOX (oxaliplatin , leucovorin , fluorouracil , and fluorouracil )

Sponsor

Sun Yat-sen University